Predicting Ebola Severity: A Clinical Prioritization Score for Ebola Virus Disease.
Despite the notoriety of Ebola virus disease (EVD) as one of the world's most deadly infections, EVD has a wide range of outcomes, where asymptomatic infection may be almost as common as fatality. With increasingly sensitive EVD diagnosis, there is a need for more accurate prognostic tools that objectively stratify clinical severity to better allocate limited resources and identify those most in need of intensive treatment.



This retrospective cohort study analyses the clinical characteristics of 158 EVD(+) patients at the GOAL-Mathaska Ebola Treatment Centre, Sierra Leone. The prognostic potential of each characteristic was assessed and incorporated into a statistically weighted disease score. The mortality rate among EVD(+) patients was 60.8% and highest in those aged <5 or >25 years (p<0.05). Death was significantly associated with malaria co-infection (OR = 2.5, p = 0.01). However, this observation was abrogated after adjustment to Ebola viral load (p = 0.1), potentially indicating a pathologic synergy between the infections. Similarly, referral-time interacted with viral load, and adjustment revealed referral-time as a significant determinant of mortality, thus quantifying the benefits of early reporting as a 12% mortality risk reduction per day (p = 0.012). Disorientation was the strongest unadjusted predictor of death (OR = 13.1, p = 0.014) followed by hiccups, diarrhoea, conjunctivitis, dyspnoea and myalgia. Including these characteristics in multivariate prognostic scores, we obtained a 91% and 97% ability to discriminate death at or after triage respectively (area under ROC curve).



This study proposes highly predictive and easy-to-use prognostic tools, which stratify the risk of EVD mortality at or after EVD triage.
GOAL Global, Dublin, Ireland.|University of Lausanne, Lausanne, Switzerland.
Mary-Anne
0000-0002-8826-3870
MA
Hartley
GOAL Global, Dublin, Ireland.
Alyssa
A
Young
GOAL Global, Dublin, Ireland.
Anh-Minh
AM
Tran
GOAL Global, Dublin, Ireland.
Harry Henry
HH
Okoni-Williams
GOAL Global, Dublin, Ireland.
Mohamed
M
Suma
GOAL Global, Dublin, Ireland.
Brooke
B
Mancuso
GOAL Global, Dublin, Ireland.
Ahmed
A
Al-Dikhari
Institute of Social and Preventive Medicine, Lausanne, Switzerland.
Mohamed
M
Faouzi
D000293:Adolescent; D000328:Adult; D002648:Child; D029043:Ebolavirus / Q000235:genetics / Q000502:physiology*; D005260:Female; D019142:Hemorrhagic Fever, Ebola / Q000175:diagnosis* / Q000401:mortality / Q000821:virology; D006801:Humans; D008297:Male; D011379:Prognosis; D012189:Retrospective Studies; D012807:Sierra Leone; D055815:Young Adult